ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

HEW Says Patent Delays Temporary

August 25, 1978

Health Reform Plans Offer Difficult Choices For Patients, Researchers, Practitioners

February 25, 1994

Congress Nearing Final Action On Appropriations, But Potential GRH Cuts Leaves Outlook Unclear

September 12, 1986

Groups Urge FDA To Take Action Against Tobacco Products

June 27, 2014

Eight Scientists Receive $800,000 From Milken

January 12, 1990

Cooperative Group Massacre Hurt Some Of Best CCOPs Which May Go Unfunded

March 27, 1987